Anthony David Baxter

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom.

deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom.

deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom.

deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom.